PURPOSE OF REVIEW: Significant progress has been made over recent years in uncovering the B-cell tolerance mechanisms that control development of autoreactive antibodies. This review examines current knowledge on the regulation and selection of autoreactive B cells in mouse models, and in healthy humans and patients with autoimmune disorders. RECENT FINDINGS: Autoreactive B cells undergo stringent selection either in the bone marrow or peripheral circulation by deletion, induction of anergy, or receptor editing. There is growing evidence that receptor editing represents the primary physiologic B-cell tolerance mechanism. Several checkpoints against autoreactive B cells have been established in bone marrow and peripheral blood of healthy humans. Recent studies demonstrate that some autoimmune disorders are associated with several alterations in B-cell tolerance checkpoints and often lead to a greater number of autoreactive B cells in the circulation. SUMMARY: Discovering the precise nature of B-cell tolerance alterations in patients with autoimmune diseases will lead to the identification of new targets for therapeutic interventions in patients with these disorders.
PURPOSE OF REVIEW: Significant progress has been made over recent years in uncovering the B-cell tolerance mechanisms that control development of autoreactive antibodies. This review examines current knowledge on the regulation and selection of autoreactive B cells in mouse models, and in healthy humans and patients with autoimmune disorders. RECENT FINDINGS: Autoreactive B cells undergo stringent selection either in the bone marrow or peripheral circulation by deletion, induction of anergy, or receptor editing. There is growing evidence that receptor editing represents the primary physiologic B-cell tolerance mechanism. Several checkpoints against autoreactive B cells have been established in bone marrow and peripheral blood of healthy humans. Recent studies demonstrate that some autoimmune disorders are associated with several alterations in B-cell tolerance checkpoints and often lead to a greater number of autoreactive B cells in the circulation. SUMMARY: Discovering the precise nature of B-cell tolerance alterations in patients with autoimmune diseases will lead to the identification of new targets for therapeutic interventions in patients with these disorders.
Authors: Zhongyu Zhu; Haiyan Rebekah Qin; Weizao Chen; Qi Zhao; Xiaoying Shen; Robert Schutte; Yanping Wang; Gilad Ofek; Emily Streaker; Ponraj Prabakaran; Genevieve G Fouda; Hua-Xin Liao; John Owens; Mark Louder; Yongping Yang; Kristina-Ana Klaric; M Anthony Moody; John R Mascola; Jamie K Scott; Peter D Kwong; David Montefiori; Barton F Haynes; Georgia D Tomaras; Dimiter S Dimitrov Journal: J Virol Date: 2011-08-31 Impact factor: 5.103
Authors: Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn Journal: Front Immunol Date: 2017-05-31 Impact factor: 7.561
Authors: Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma Journal: Immunity Date: 2010-08-12 Impact factor: 31.745
Authors: Marc-Werner Dobenecker; Jonas Marcello; Annette Becker; Eugene Rudensky; Natarajan V Bhanu; Thomas Carrol; Benjamin A Garcia; Rabinder Prinjha; Vyacheslav Yurchenko; Alexander Tarakhovsky Journal: FEBS Lett Date: 2020-08-29 Impact factor: 4.124